Skip to main content
Oregon.gov Homepage

Medication-Assisted Treatment and Recovery (U MATR)

The Oregon Health Authority, operating under OAR 415.020, is in charge of helping and regulating addiction prevention and treatment services in Oregon. Opioid Treatment Programs dispense and administer medications for the treatment of opioid addiction. This includes delivery of counseling, supportive services and medical services to program participants.

Know your rights

Information for providers

Frequently asked questions

Answer:

Methadone is a full antagonist (fully blocking the opioid receptors in the brain). Research shows several positive benefits to methadone reatment, including:

  • Reduced intravenous drug use
  • Decreased risk of overdose
  • Reduced exposure to infectious diseases (including Hepatitis C, B as well as HIV)
  • Up to 30% reduced mortality
  • Reduced criminal behavior
  • Improved pregnancy outcomes 
  • Greatly reduced withdrawal symptoms and cravings
  • Ability to stay in a structured treatment environment for longer periods of time than individuals undergoing other types of treatment
Answer:

Buprenorphine and naltrexone are also available for medication-assisted treatment of opioid dependence.

  • Buprenophine: Unlike methadone, which is a “full” agonist, buprenorphine is a partial agonist (partially binding to opioid receptors in the brain).
  • Naltrexone is a full antagonist (fully blocking the opioid receptors in the brain).

Methadone, buprenorphine and naltrexone are all highly effective medications for the treatment of opioid dependence. They may or may not be appropriate for the patient based on several other factors.

Answer:

Currently, in the United States:

  • Methadone can only be dispensed at an approved and regulated opiate treatment program.
  • Naltrexone and buprenorphine can be prescribed by a physician for use by the patient in a non-office setting.

As with any medication-based intervention, engagement in treatment and a psychosocial support system can contribute greatly to the patient's success.

Answer:

Opioid addiction is one of Oregon’s most pressing public health issues.

  • Lost productivity, overdose, and reduced quality of life are just some of the impacts to individuals, families, and society.
  • Even when the individual has a strong desire to stop their usage, stopping opiate use after a long period can cause unpleasant physical and psychological withdrawal systems; many long time users find it difficult to not use opiates when faced with these symptoms, thus continuing the cycle of addiction.

Medication-Assisted Treatment (MAT), including the use of methadone, is a medically monitored therapeutic intervention designed to assist opiate dependent individuals improve their overall quality of life and begin the recovery process, that involves case management, counseling and medication management.

 

Program Contact:

Dr. John W. McIlveen
Program and Policy Development Specialist
State Opioid Treatment Authority

Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how

×